Dare Bioscience, Inc. (DARE) earnings
Quarterly results of Dare Bioscience, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Dare Bioscience, Inc. was expected to report around October 22, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Dare Bioscience, Inc. reported revenue of $187.5K and a net loss of $3M.
Diluted earnings per share were -$0.20.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $187.5K | - | -$3M | -$0.20 |
| Q1 FY2026 | $152.5K | +499.6% | -$3M | -$0.21 |
| Q4 FY2025 | - | - | -$1.4M | - |
| Q3 FY2025 | $2.3K | -94.6% | -$3.6M | -$0.28 |
| Q2 FY2025 | - | - | -$4M | -$0.45 |
| Q1 FY2025 | $25.4K | - | -$4.4M | -$0.50 |
| Q4 FY2024 | -$63.6K | - | -$5.5M | - |
| Q3 FY2024 | $41.7K | - | -$4.7M | -$0.55 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
When is Dare Bioscience, Inc.'s next earnings date?
Dare Bioscience, Inc. was expected to report around October 22, 2026; nothing is on file with the SEC yet.
What were Dare Bioscience, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Dare Bioscience, Inc. reported revenue of $187.5K and a net loss of $3M. The figures come from its filing with the SEC.
Get an email when DARE reports
Follow DARE and we email you its next results the day they are filed, with the numbers explained.